IDYA

IDEAYA Biosciences (IDYA)

About IDEAYA Biosciences (IDYA)

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ and GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Details

Daily high

$31.72

Daily low

$30.84

Price at open

$30.88

52 Week High

$39.28

52 Week Low

$13.45

Market cap

2.7B

Dividend yield

0.00%

Volume

115,293

Avg. volume

975,920

P/E ratio

-23.43

IDEAYA Biosciences News